| Classification and personalized prognosis in myeloproliferative neoplasms J Grinfeld, J Nangalia, EJ Baxter, DC Wedge, N Angelopoulos, R Cantrill, ... New England Journal of Medicine 379 (15), 1416-1430, 2018 | 574 | 2018 |
| Epstein-Barr virus and its association with disease-a review of relevance to general practice A Fugl, CL Andersen BMC family practice 20, 1-8, 2019 | 222 | 2019 |
| Machine learning can identify newly diagnosed patients with CLL at high risk of infection R Agius, C Brieghel, MA Andersen, AT Pearson, B Ledergerber, ... Nature communications 11 (1), 363, 2020 | 98 | 2020 |
| Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study AL Sørensen, SU Mikkelsen, TA Knudsen, ME Bjørn, CL Andersen, ... haematologica 105 (9), 2262, 2020 | 97 | 2020 |
| A phase II study of vorinostat (MK‐0683) in patients with polycythaemia vera and essential thrombocythaemia CL Andersen, MF McMullin, E Ejerblad, S Zweegman, C Harrison, ... British journal of haematology 162 (4), 498-508, 2013 | 81 | 2013 |
| A systematic review of health‐related quality of life in longitudinal studies of myeloma patients LK Nielsen, M Jarden, CL Andersen, H Frederiksen, N Abildgaard European journal of haematology 99 (1), 3-17, 2017 | 79 | 2017 |
| Changes in prescription routines for treating hypothyroidism between 2001 and 2015: an observational study of 929,684 primary care patients in Copenhagen BB Medici, B Nygaard, JL La Cour, MK Grand, V Siersma, ... Thyroid 29 (7), 910-919, 2019 | 51 | 2019 |
| Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death CL Andersen, VD Siersma, HC Hasselbalch, H Lindegaard, ... American journal of hematology 88 (10), 843-847, 2013 | 50 | 2013 |
| Prevalence and clinical significance of neutropenia discovered in routine complete blood cell counts: a longitudinal study CL Andersen, D Tesfa, VD Siersma, H Sandholdt, H Hasselbalch, ... Journal of Internal Medicine 279 (6), 566-575, 2016 | 46 | 2016 |
| Somatic mutations of the CREBBP and EP300 genes affect response to histone deacetylase inhibition in malignant DLBCL clones CL Andersen, F Asmar, T Klausen, H Hasselbalch, K Grønbæk Leukemia research reports 2 (1), 1-3, 2013 | 43 | 2013 |
| Strategies to improve patient-reported outcome completion rates in longitudinal studies LK Nielsen, M King, S Möller, M Jarden, CL Andersen, H Frederiksen, ... Quality of Life Research 29, 335-346, 2020 | 34 | 2020 |
| A ssociation of the blood eosinophil count with hematological malignancies and mortality CL Andersen, VD Siersma, HC Hasselbalch, H Vestergaard, R Mesa, ... American journal of hematology 90 (3), 225-229, 2015 | 33 | 2015 |
| Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark N Brochmann, EM Flachs, AI Christensen, M Bak, CL Andersen, K Juel, ... Clinical epidemiology, 23-33, 2018 | 29 | 2018 |
| Circulating YKL‐40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state ME Bjørn, CL Andersen, MK Jensen, HC Hasselbalch European Journal of Haematology 93 (3), 224-228, 2014 | 27 | 2014 |
| Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory … R Borg, F Persson, V Siersma, B Lind, N de Fine Olivarius, CL Andersen Diabetic Medicine 35 (12), 1700-1706, 2018 | 26 | 2018 |
| Safety and efficacy of combination therapy of interferon-alpha2+ JAK1-2 inhibitor in the Philadelphia-negative chronic myeloproliferative neoplasms. Preliminary results from … SU Mikkelsen, L Kjær, V Skov, ME Bjørn, CL Andersen, OW Bjerrum, ... Blood 126 (23), 824, 2015 | 24 | 2015 |
| A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis CL Andersen, NB Mortensen, TW Klausen, H Vestergaard, OW Bjerrum, ... Haematologica 99 (1), e5, 2014 | 23 | 2014 |
| Association of the blood eosinophil count with end-organ symptoms OW Bjerrum, V Siersma, HC Hasselbalch, B Lind, CL Andersen Annals of Medicine and Surgery 45, 11-18, 2019 | 22 | 2019 |
| Systemic mastocytosis-a systematic review CL Andersen, TK Kristensen, MT Severinsen, MB Møller, H Vestergaard, ... Dan Med J 59 (3), A4397, 2012 | 22 | 2012 |
| Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations HM Nielsen, CL Andersen, M Westman, LS Kristensen, F Asmar, ... Scientific Reports 7 (1), 6774, 2017 | 19 | 2017 |
